S.c. injections of bovine intestinal alkaline phosphatase (DrugBank: Alkaline Phosphatase)
1 disease告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
46 | 悪性関節リウマチ | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01416493 (ClinicalTrials.gov) | May 2011 | 11/8/2011 | Bovine Intestinal Alkaline Phosphatase (bIAP) Modulating Rheumatoid Arthritis | An OPEN LABEL Phase II Safety Study of Bovine Intestinal Alkaline Phosphatase (bIAP), an Inflammation Modulating Moiety, in RA Patients | Acute Rheumatoid Arthritis | Drug: s.c. injections of bovine intestinal Alkaline Phosphatase | Alloksys Life Sciences B.V. | Aix Scientifics | Completed | 18 Years | N/A | Both | 6 | Phase 1;Phase 2 | United Kingdom |